Bullish Trending Up
5day MA crossing over the 8day MA, both are arching upward. Look to other instances of this occurrence and generally is followed by a spike in price action. I expect this should break out above $13 by next week.
The sell off this week was due to the entire market sell off after it was revealed in a secret memo that MM’s were notified before the market collapse back in April and the crash was due to a massive short sell. This has nothing to do with Inovio who also just filed a new 8K report disclosing the termination of an exclusive licensing agreement with GeneOne/VXG, (their long time manufacturing partner)for the Inovio’s Cellectra DNA Vaccine Delivery Smart Device. This is great news, because Inovio will now be able to licenses its use to other global suppliers. This is key as their medicine is next-generation with the proven ability to cure many major diseases such as cancers, HIV, Ebola, Covid-19. The medicines all must be administered with this proprietary DNA Medicine delivery device.
The age of DNA medicine is here.
The sell off this week was due to the entire market sell off after it was revealed in a secret memo that MM’s were notified before the market collapse back in April and the crash was due to a massive short sell. This has nothing to do with Inovio who also just filed a new 8K report disclosing the termination of an exclusive licensing agreement with GeneOne/VXG, (their long time manufacturing partner)for the Inovio’s Cellectra DNA Vaccine Delivery Smart Device. This is great news, because Inovio will now be able to licenses its use to other global suppliers. This is key as their medicine is next-generation with the proven ability to cure many major diseases such as cancers, HIV, Ebola, Covid-19. The medicines all must be administered with this proprietary DNA Medicine delivery device.
The age of DNA medicine is here.
Wyłączenie odpowiedzialności
Informacje i publikacje przygotowane przez TradingView lub jego użytkowników, prezentowane na tej stronie, nie stanowią rekomendacji ani porad handlowych, inwestycyjnych i finansowych i nie powinny być w ten sposób traktowane ani wykorzystywane. Więcej informacji na ten temat znajdziesz w naszym Regulaminie.